Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
ContributorsCostedoat-Chalumeau, Nathalie; Galicier, Lionel; Aumaître, Olivier; Francès, Camille; Le Guern, Véronique; Lioté, Frédéric; Smail, Amar; Limal, Nicolas; Perard, Laurent; Desmurs-Clavel, Hélène; Boutin, Du Le Thi Huong; Asli, Bouchra; Kahn, Jean-Emmanuel; Pourrat, Jacques; Sailler, Laurent; Ackermann, Félix; Papo, Thomas; Sacré, Karim; Fain, Olivier; Stirnemann, Jérôme; Cacoub, Patrice; Jallouli, Moez; Leroux, Gaelle; Cohen-Bittan, Judith; Tanguy, Marie-Laure; Hulot, Jean-Sébastien; Lechat, Philippe; Musset, Lucile; Amoura, Zahir; Piette, Jean-Charles
Published inAnnals of the rheumatic diseases, vol. 72, no. 11, p. 1786-1792
Publication date2013
Abstract
Keywords
- Adult
- Antirheumatic Agents/administration & dosage/blood
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Monitoring/methods
- Female
- France
- Humans
- Hydroxychloroquine/administration & dosage/blood
- Lupus Erythematosus, Systemic/drug therapy
- Male
- Middle Aged
- Prospective Studies
- Treatment Outcome
Affiliation Not a UNIGE publication
Citation (ISO format)
COSTEDOAT-CHALUMEAU, Nathalie et al. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study). In: Annals of the rheumatic diseases, 2013, vol. 72, n° 11, p. 1786–1792. doi: 10.1136/annrheumdis-2012-202322
Main files (1)
Article (Published version)
Identifiers
- PID : unige:78439
- DOI : 10.1136/annrheumdis-2012-202322
- PMID : 23144449
ISSN of the journal0003-4967